Author

Santina Quarta

Observed names: QUARTA SANTINA, QUARTA, SANTINA MARIA, Quarta Santina, Quarta, S., S Quarta, S. Quarta, Santina M Quarta, Santina Maria Quarta

Institution: University of Padua

Observed institutions: University of Bern, University of Bonn, Harvard University, University of Padua, Friedrich-Alexander-Universität Erlangen-Nürnberg, Hokkaido University, University of Pavia, Hôpital Beaujon, The Royal Free Hospital, University Hospital Zurich, Institute of Clinical and Experimental Medicine, Azienda Ospedale - Università Padova, Consorzio per la Ricerca Sanitaria, University College London

ORCID: 0000-0002-9348-1485

Observed ORCID: 0000-0002-9348-1485

OpenAlex ID: A5034856491

The Cyclin-Dependent Kinase Inhibitors Olomoucine and Roscovitine Arrest Human Fibroblasts in G1 Phase by Specific Inhibition of CDK2 Kinase Activity

1998 · Francesca Alessi, Santina Quarta, et al. · Experimental Cell Research · 138

Squamous cell carcinoma antigen‐immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma

2005 · Luca Beneduce, Francesco Castaldi, et al. · Cancer · 123

PDF

SERPINB3, apoptosis and autoimmunity

2009 · Laura Vidalino, Andrea Doria, et al. · Autoimmunity Reviews · 100

The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma

2018 · Daniela Pollutri, Clarissa Patrizi, et al. · Cell Death and Disease · 90

PDF

SERPINB3 induces epithelial–mesenchymal transition

2010 · Santina Quarta, Laura Vidalino, et al. · The Journal of Pathology · 88

Biodistribution of Intratracheal, Intranasal, and Intravenous Injections of Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles in a Mouse Model for Drug Delivery Studies

2023 · Anna Maria Tolomeo, Gaia Zuccolotto, et al. · Pharmaceutics · 86

PDF

Progressive increase of SCCA‐IgM immune complexes in cirrhotic patients is associated with development of hepatocellular carcinoma

2006 · Patrizia Pontisso, Santina Quarta, et al. · International Journal of Cancer · 79

PDF

MiR-30e-3p Influences Tumor Phenotype through MDM2 / TP53 Axis and Predicts Sorafenib Resistance in Hepatocellular Carcinoma

2020 · Laura Gramantieri, Daniela Pollutri, et al. · Cancer Research · 73

PDF

Carbon Monoxide-Mediated Activation of Large-Conductance Calcium-Activated Potassium Channels Contributes to Mesenteric Vasodilatation in Cirrhotic Rats

2007 · Massimo Bolognesi, David Sacerdoti, et al. · Journal of Pharmacology and Experimental Therapeutics · 72

Biological and clinical implications of HBV infection in peripheral blood mononuclear cells

2008 · Patrizia Pontisso, Laura Vidalino, et al. · Autoimmunity Reviews · 66

SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis

2014 · C Turato, A Vitale, et al. · British Journal of Cancer · 61

PDF

Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells

2014 · Stefania Cannito, Cristian Turato, et al. · Oncotarget · 59

PDF

SERPINB3 modulates TGF-β expression in chronic liver disease

2010 · Cristian Turato, Fiorella Calabrese, et al. · Laboratory Investigation · 52

MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma

2019 · Cristian Turato, Francesca Fornari, et al. · Journal of Clinical Medicine · 46

PDF

Over-expression of SERPINB3 in hepatoblastoma: A possible insight into the genesis of this tumour?

2011 · Cristian Turato, Marie Annick Buendia, et al. · European Journal of Cancer · 46

PDF

The protease‐inhibitor SerpinB3 as a critical modulator of the stem‐like subset in human cholangiocarcinoma

2021 · Margherita Correnti, Andrea Cappon, et al. · Liver International · 42

PDF

The antiproliferative effect of β‐carotene requires p21waf1/cip1 in normal human fibroblasts

2000 · Lucia A. Stivala, Monica Savio, et al. · European Journal of Biochemistry · 40

Monitoring SCCA‐IgM complexes in serum predicts liver disease progression in patients with chronic hepatitis

2008 · A. Biasiolo, L. Chemello, et al. · Journal of Viral Hepatitis · 39

PDF

SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity

2015 · Cristian Turato, Stefania Cannito, et al. · Scientific Reports · 36

PDF

SerpinB3 Promotes Pro-fibrogenic Responses in Activated Hepatic Stellate Cells

2017 · Erica Novo, Gianmarco Villano, et al. · Scientific Reports · 32

PDF

Synthesis, chemical characterization and cancer cell growth-inhibitory activities of Cu( ii ) and Ru( iii ) aliphatic and aromatic dithiocarbamato complexes

2018 · L. Brustolin, C. Nardon, et al. · Dalton Transactions · 31

Re-programming pullulan for targeting and controlled release of doxorubicin to the hepatocellular carcinoma cells

2017 · Anna Balasso, Stefano Salmaso, et al. · European Journal of Pharmaceutical Sciences · 31

Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles

2016 · Satadru Jha, Federico Ramadori, et al. · Bioconjugate Chemistry · 31

Effects of β-carotene and α-tocopherol on photogenotoxicity induced by 8-methoxypsoralen: The role of oxygen

1996 · Livia Bianchi, Raffaele Melli, et al. · Mutation Research/Genetic Toxicology · 31

SerpinB3 Differently Up-Regulates Hypoxia Inducible Factors -1α and -2α in Hepatocellular Carcinoma: Mechanisms Revealing Novel Potential Therapeutic Targets

2019 · Stefania Cannito, Beatrice Foglia, et al. · Cancers · 28

Works count: 187

Citation count: 1,942

H-index: 27

I10-index: 46